Multipotent cell lineages in early mouse development depend on SOX2 function

  1. Ariel A. Avilion,
  2. Silvia K. Nicolis1,
  3. Larysa H. Pevny2,
  4. Lidia Perez3,
  5. Nigel Vivian, and
  6. Robin Lovell-Badge4
  1. Division of Developmental Genetics, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK

Abstract

Each cell lineage specified in the preimplantation mammalian embryo depends on intrinsic factors for its development, but there is also mutual interdependence between them. OCT4 is required for the ICM/epiblast lineage, and at transient high levels for extraembryonic endoderm, but also indirectly through its role in regulatingFgf4 expression, for the establishment and proliferation of extraembryonic ectoderm from polar trophectoderm. The transcription factor SOX2 has also been implicated in the regulation of Fgf4expression. We have used gene targeting to inactivate Sox2, examining the phenotypic consequences in mutant embryos and in chimeras in which the epiblast is rescued with wild-type ES cells. We find a cell-autonomous requirement for the gene in both epiblast and extraembryonic ectoderm, the multipotent precursors of all embryonic and trophoblast cell types, respectively. However, an earlier role within the ICM may be masked by the persistence of maternal protein, whereas the lack of SOX2 only becomes critical in the chorion after 7.5 days postcoitum. Our data suggest that maternal components could be involved in establishing early cell fate decisions and that a combinatorial code, requiring SOX2 and OCT4, specifies the first three lineages present at implantation.

Keywords

Footnotes

  • Present addresses: 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy; 2Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; 3EMBL, Meyerhofstrasse 1, D-69117 Heidelberg, Germany.

  • 4 Corresponding author.

  • E-MAIL rlovell{at}nimr.mrc.ac.uk; FAX 44-020-8906-4477.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.224503.

  • Supplementary material is available at http://www.genesdev.org.

    • Received April 11, 2002.
    • Accepted October 29, 2002.
| Table of Contents

Life Science Alliance